{
    "SPADE_UN_11608": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11608",
            "Peptide Name": "FV-CE (FV7 and CE(Cecropin A (1",
            "Source": "Synthetic construct",
            "Family": "FV7 and CE(Cecropin A (1",
            "Gene": "Not found",
            "Sequence": "FRIRVRVKWKLFKKI",
            "Sequence Length": 15,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.28178190] Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=1 μM), Bacillus subtilis CMCC 63501 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=0.5 μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2 μM), Escherichia coli UB 1005 (MIC=2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).",
            "Hemolytic Activity": "[Ref.28178190] 1% hemolysis at 2 μM, 5% hemolysis at 128 μM against human red cells",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "The hybrid peptide displayed an unordered conformation in phosphate buffer.",
            "Formula": "C99H165N29O16",
            "Mass": 2017.55,
            "PI": 12.0,
            "Net Charge": 7,
            "Hydrophobicity": -0.21,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against the Gram-negative and Gram-positive bacteria",
            "Literature": [
                {
                    "Title": "High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7",
                    "Pubmed ID": "28178190",
                    "Reference": "Int J Mol Sci. 2017 Feb 6;18(2).",
                    "Author": "Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28178190"
                }
            ],
            "Frequent Amino Acids": "KRF",
            "Absent Amino Acids": "ACDEGHMNOPQSTUY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 9,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11583",
                    "Similarity": 1.0,
                    "Sequence": "CKRFRIRVRV"
                },
                {
                    "SPADE_ID": "SPADE_UN_05925",
                    "Similarity": 1.0,
                    "Sequence": "KQFRIRVRV"
                },
                {
                    "SPADE_ID": "SPADE_UN_05933",
                    "Similarity": 1.0,
                    "Sequence": "KRFRIRVRV"
                }
            ]
        }
    }
}